PARIS, March 31, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved Sarclisa (isatuximab-irfc) in combination with…
Home »
Study finds combination therapy suppresses pancreatic tumor growth in mice
UCLA Jonsson Comprehensive Cancer Center researchers have uncovered a potential new way to target pancreatic tumors that express high intratumoral…
Regeneron’s Casirivimab and Imdevimab Antibody Cocktail for COVID-19 is First Combination Therapy to Receive FDA Emergency Use Authorization
TARRYTOWN, N.Y., November 21, 2020 – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the antibody cocktail casirivimab and imdevimab administered…
Drug combination reverses hypersensitivity to noise in a model of autism spectrum disorder
People with autism often experience hypersensitivity to noise and other sensory input. MIT neuroscientists have now identified two brain circuits…
Combination of drugs may combat deadly drug-resistant fungus
As health officials in New Jersey, Illinois and New York State scramble to contain the spread of a highly infectious…
Epigenetic study provides new approaches to combination therapies for aggressive cancers
Epigenetic processes enable cells to respond to changes in their environment by regulating the activity of their genes. One of…
Cancer-killing combination therapies unveiled with new drug-screening tool
UC San Francisco scientists have designed a large-scale screen that efficiently identifies drugs that are potent cancer-killers when combined, but…